Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease David Moadel Thu, October 8, 2026 at 10:09 AM EDT 4 min read TLRY -3.64% CGC -1.88% SPY -0.11% ACB -1.35% CGC -1.88% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
TLRY fell 7% after cannabis revenue shrank while beer drove a 23% revenue record; CGC and ACB each dipped just 1%.
MJ and SPY each fell just 0.3%, confirming the selloff targets Tilray Brands specifically rather than the broader cannabis sector.
Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now, and Tilray Brands didn't make the cut. Enter your email to see the names that beat TLRY. The report is free. Enter your email and see if any of your stocks made the cut.
A Q1 FY2027 revenue record from Tilray Brands (NASDAQ:TLRY) is drawing heavy selling, because the segment that built the company's following moved the wrong way. Tilray Brands shares are at $3.56, down 4% this morning, as the company's cannabis sales contracted while its beer and distribution units carried the top line.
Meanwhile, Canopy Growth (NASDAQ:CGC) stock trades at $0.87, down 1%, a far softer slide than the drop hitting Tilray Brands stock. At the same time, Aurora Cannabis (NASDAQ:ACB) shares are at $4.41, down 1%, another modest retreat for a pure-play cannabis producer.
As a gauge of the wider cannabis group, the Amplify Alternative Harvest ETF (NYSEARCA:MJ) is at $24.31, down 0.3%. For a broad-market read, the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is at $774.83, down 0.3%. That spread marks the selloff as a reaction to Tilray's own numbers, since the cannabis fund and the S&P 500 fund are each slipping far less.
Why Didn't TLRY Make The Top 10 List?
24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now.
The report is free, and you can see why we think each stock is a top investment today.
Enter Your Email and See the Ten →
At first glance, Tilray delivered. Its net revenue for Q1 FY2027 rose 23% year over year to a first-quarter record, while its gross margin expanded and its gross profit hit a new high for the period. Tilray's cannabis net revenue fell to $56.1 million from the prior-year period, making that business the one major segment to shrink. Beer led the gains, as the company's beverage revenue grew sharply following the BrewDog acquisition and its distribution sales rose too.
Its profitability slipped anyway, as Tilray's adjusted earnings before interest, taxes, depreciation and amortization declined year over year despite the higher revenue and gross profit, and the company pointed to global fuel surcharges as one burden on the quarter and reaffirmed its full-year adjusted earnings guidance. On the balance sheet, Tilray Brands said it ended the quarter in a net cash position and has reduced outstanding debt during the fiscal year to date.
Tilray Brands now spans cannabis, beverage, distribution and wellness, so beer and pharmaceutical wholesaling can carry group revenue to a record while the cannabis business contracts underneath. Chief Executive Irwin D. Simon leaned into that mix when presenting Tilray's results, stating, "We are no longer dependent on a single market or regulatory catalyst."
Canopy Growth and Aurora Cannabis remain far more concentrated in cannabis itself. That's why a Tilray quarter built on beer and pharmaceutical distribution doesn't read across directly to either company.
The focus turns to whether Tilray Brands' cannabis segment stabilizes over the coming quarters, since the revenue record now leans heavily on beer and distribution. The company's reaffirmed full-year guidance sets a clear bar for the remainder of the fiscal year. A return to growth in Tilray's cannabis business could cast this quarter as a temporary dip.
Traders may want to keep an eye on whether fuel-surcharge pressure on Tilray's adjusted earnings eases, since that burden helped push profitability lower despite record sales. Canopy Growth and Aurora Cannabis offer a cleaner read on cannabis demand, so further weakness in Canopy Growth stock or Aurora Cannabis stock could point to a problem extending beyond Tilray.
If you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today. And TLRY wasn't one of them.
They combed the entire market. It's not 10 ideas, not 10 stocks everyone is talking about, it's what their research points to as the 10 best stocks to buy right now, and it's free. Read more here and see which stocks made the list -->>
Contact editorial@247wallst.com for any questions or corrections.
